Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Robert DiBianco"'
Autor:
Robert DiBianco
Publikováno v:
The American Journal of Medicine. 115:480-488
The success of angiotensin-converting enzyme (ACE) inhibitors in reducing morbidity and mortality in patients with heart failure has led to investigations of other inhibitors of the renin-angiotensin-aldosterone system. Although ACE inhibitors remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e004ed675dd1169ebd2b668e61e012dc
https://doi.org/10.1016/s0002-9343(03)00265-1
https://doi.org/10.1016/s0002-9343(03)00265-1
Autor:
Michael M. Givertz, Evan Loh, Jay N. Cohn, Niki E. Kantrowitz, John C. Burnett, Kanu Chatterjee, C. Richard Conti, Joseph A. Franciosa, Mihai Gheorghiade, Prakash Deedwania, Steven K. Krueger, Peter E. Carson, James B. Young, William H. Gaasch, Beverly H. Lorell, Alan H. Gradman, Robert M. Kohn, Gregg C. Fonarow, Eduardo de Marchena, Wilson S. Colucci, George I. Mallis, Rodney H. Falk, Joseph S. Alpert, Michael B. Fowler, Steven R. Goldsmith, Marrick L. Kukin, Carl V. Leier, Keith C. Ferdinand, Mark A. Creager, Blase A. Carabello, Thomas S. Johnston, Syed A.Q. Jafri, Bodh I. Jugdutt, Inder S. Anand, Robert DiBianco, William B. Hood, Paul W. Armstrong, Frederic R. Kahl, Barry M. Massie, Peter R. Kowey, Robert J. Cody, Michael B. Higginbotham, Gary S. Francis, W. Bruce Dunkman, Jonathan Abrams, Edward K. Kasper, Maria Rosa Costanzo, Thomas J. Donohue, Edward M. Geltman, Charles L. Curry, Steven A. Goldman, Ross D. Fletcher, William T. Abraham, Thierry H. Le Jemtel, Thomas D. Giles, Kirkwood F. Adams, Arnold M. Katz, Richard J. Katz, Sidney Goldstein, Frank James, Andrew G. Kumpuris, Anthony N. DeMaria, Arthur M. Feldman, T. Barry Levine, Ernie Haeusslein, Marvin A. Konstam, Milton Packer, Teresa De Marco, J. Thomas Heywood, Mariell Jessup, John B. Kostis, James A. Hill, George A. Beller, Robert C. Bourge, Jerre F. Lutz, Jeffrey D. Hosenpud, Ray E. Hershberger, Keith D. Aaronson, Forrester A. Lee, Denise D. Hermann, Stephen S. Gottlieb, John Gregory, Donna Mancini, Louis J. Dell'Italia, Henry S. Loeb, Stuart D. Katz, Chang Seng Liang, Paul Douglass, Philip C. Kirlin, Barry H. Greenberg, Guillermo Cintron, Robert P. Frantz, G. William Dec, Joe L. Hargrove, Alan J. Bank, David W. Baker, Uri Elkayam, Jeffrey S. Borer, Edward M. Gilbert
Publikováno v:
The American Journal of Cardiology. 83:1A-38A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5896ad6664493464133866be9be5b8f8
https://doi.org/10.1016/s0002-9149(98)00850-9
https://doi.org/10.1016/s0002-9149(98)00850-9
Autor:
George T Broderick, Lukas Makris, Robert DiBianco, Ewa J. Rucinska, John B. Kostis, Enalapril-Captopril Investigators, Paulette A. Lyle, Stephen S. Gottlieb, Sol I. Rajfer, Roberto M. Lang
Publikováno v:
American Heart Journal. 128:551-556
Significant decreases in blood pressure (BP) may occur when administration of angiotensin-converting enzyme (ACE) inhibitors is initiated for the treatment of heart failure. The purpose of this study was to compare the safety and tolerability of reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abe1dd1f5646df3555b6d9f44cf0e01b
https://doi.org/10.1016/0002-8703(94)90631-9
https://doi.org/10.1016/0002-8703(94)90631-9
Publikováno v:
Clinical Cardiology. 17:103-116
Summary: During the past few years, a number of new antiarrhythmic agents have become available for use in the United States, encainide has been withdrawn from use, and others have had indications for use modified. Therefore, a meeting of arrhythmia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af455a1155a46ac0813389d23c116587
https://doi.org/10.1002/clc.4960170303
https://doi.org/10.1002/clc.4960170303
Publikováno v:
Journal of the American College of Cardiology. 22(6):1557-1563
Objectives. This study was performed to the efficacy, safety and clinical consequences of abrupt cessation of quinapril therapy in a placebo-controlled,, randomized, double-blind withdrawal trial. Background. Angiotensin-converting enzyme inhibitor t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b61ab30e32593ee8e927f7306f5b99
Autor:
P. K. Tandon, Milton Packer, Eric J. Eichhorn, James Shannon, Gerald C. Timmis, Robert DiBianco, Paul E. Fenster
Publikováno v:
Journal of the American College of Cardiology. 21(3):634-640
The aim of this study was to determine the prognostic significance of alterations in serum magnesium in patients with moderate to severe congestive heart failure.Reductions in serum magnesium have been postulated to play a role in promoting arrhythmi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d015b930177487ed5ca38f4ff0e9218d
Autor:
Frank L. Canosa, Tyson Bennett, Fred W. Schoomaker, Najam A. Awan, Stephen P. Glasser, Virinderjit S. Bamrah, M.D. Robert Dibianco, William Barry, David T. Kawanishi, Jang B. Singh
Publikováno v:
Clinical Cardiology. 15:519-524
Amlodipine, a potent long-acting dihydropyridine calcium antagonist, was compared with placebo in a parallel, randomized, double-blind study in 134 patients with chronic stable angina pectoris maintained on beta-adrenergic blocking agents. After a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b19038aa27839b4edb7222b47a8cad
https://doi.org/10.1002/clc.4960150709
https://doi.org/10.1002/clc.4960150709
Autor:
Robert DiBianco
Publikováno v:
The American Journal of Cardiology. 69:56-62
The antianginal efficacy of bepridil, a calcium antagonist with an extended plasma elimination half-life, has been compared with placebo and the calcium antagonists nifedipine and diltiazem in patients refractory to diltiazem. The earliest observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4df48efe2a324f7dd0a9252771a2a6f
https://doi.org/10.1016/0002-9149(92)90960-7
https://doi.org/10.1016/0002-9149(92)90960-7
Autor:
Robert DiBianco
Publikováno v:
Journal of Cardiovascular Pharmacology. 19:S38-S44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d04a3bb7ca45376a224b0579ad91043
https://doi.org/10.1097/00005344-199219004-00009
https://doi.org/10.1097/00005344-199219004-00009
Autor:
Richard J. Rodeheffer, J. Sollano, Uri Elkayam, George I. Mallis, Steven M. Zeldis, Joseph R. Carver, Russell J. Ivanhoe, Marrick L. Kukin, David L. DeMets, Milton Packer, Robert DiBianco, William J. Bommer, P. K. Tandon, Grady H. Hendrix, James A. Shannon
Publikováno v:
New England Journal of Medicine. 325:1468-1475
Background. Milrinone, a phosphodiesterase inhibitor, enhances cardiac contractility by increasing intracellular levels of cyclic AMP, but the long-term effect of this type of positive inotropic agent on the survival of patients with chronic heart fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65b73848152dec8a55fde859b940388b
https://doi.org/10.1056/nejm199111213252103
https://doi.org/10.1056/nejm199111213252103